Literature DB >> 23702234

Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats.

Er-Yuan Chuang1, Kun-Ju Lin, Fang-Yi Su, Fwu-Long Mi, Barnali Maiti, Chiung-Tong Chen, Shiaw-Pyng Wey, Tzu-Chen Yen, Jyuhn-Huarng Juang, Hsing-Wen Sung.   

Abstract

This work examined the feasibility of preparing a pH-responsive nanoparticle (NP) system composed of chitosan and poly(γ-glutamic acid) conjugated with ethylene glycol tetraacetic acid (γPGA-EGTA) for oral insulin delivery in diabetic rats during an oral glucose tolerance test (OGTT). OGTT has been used largely as a model to mimic the period that comprises and follows a meal, which is often associated with postprandial hyperglycemia. Based on Förster resonance energy transfer (FRET), this work also demonstrated the ability of γPGA-EGTA to protect insulin from an intestinal proteolytic attack in living rats, owing to its ability to deprive the environmental calcium. Additionally, EGTA-conjugated NPs were effective in disrupting the epithelial tight junctions, consequently facilitating the paracellular permeation of insulin throughout the entire small intestine. Moreover, results of positron emission tomography and computer tomography demonstrated the effective absorption of the permeated insulin into the systemic circulation as well as promotion of the glucose utilization in the myocardium, and skeletal muscles of the chest wall, forelimbs and hindlimbs, resulting in a significant glucose-lowering effect. Above results indicate that as-prepared EGTA-conjugated NPs are a promising oral insulin delivery system to control postprandial hyperglycemia and thus may potentially prevent the related diabetic complications.
Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chitosan-γPGA–EGTA nanoparticles; Diabetes mellitus; Glucose utilization; Oral insulin absorption; Postprandial hyperglycemia

Mesh:

Substances:

Year:  2013        PMID: 23702234     DOI: 10.1016/j.jconrel.2013.05.006

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  5 in total

Review 1.  Therapeutic applications of hydrogels in oral drug delivery.

Authors:  Lindsey A Sharpe; Adam M Daily; Sarena D Horava; Nicholas A Peppas
Journal:  Expert Opin Drug Deliv       Date:  2014-06       Impact factor: 6.648

Review 2.  pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.

Authors:  Lin Liu; WenDong Yao; YueFeng Rao; XiaoYang Lu; JianQing Gao
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Controlled release of liraglutide using thermogelling polymers in treatment of diabetes.

Authors:  Yipei Chen; Yuzhuo Li; Wenjia Shen; Kun Li; Lin Yu; Qinghua Chen; Jiandong Ding
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

4.  Exploring the Effect of Glycerol and Hydrochloric Acid on Mesoporous Silica Synthesis: Application in Insulin Loading.

Authors:  May Kyaw Oo; Batoul Alallam; Abd Almonem Doolaanea; Alfi Khatib; Farahidah Mohamed; Bappaditya Chatterjee
Journal:  ACS Omega       Date:  2022-07-26

Review 5.  Nanoparticle Delivery Systems in the Treatment of Diabetes Complications.

Authors:  Eliana B Souto; Selma B Souto; Joana R Campos; Patricia Severino; Tatiana N Pashirova; Lucia Y Zakharova; Amélia M Silva; Alessandra Durazzo; Massimo Lucarini; Angelo A Izzo; Antonello Santini
Journal:  Molecules       Date:  2019-11-20       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.